Evidence-Based GLP-1 Information for Patients & Providers
GLP-1 research background
Evidence-Based InformationUpdated April 2026

Your Complete Guide to
Buying GLP-1
Medications

Peer-reviewed research, FDA updates, and step-by-step guidance on how to safely obtain semaglutide, tirzepatide, and other GLP-1 receptor agonists — with or without insurance.

Popular: Semaglutide, Tirzepatide, Liraglutide, Compounded GLP-1, Telehealth Prescriptions

1,200+
Clinical Studies Reviewed
8
FDA-Approved GLP-1 Drugs
15%+
Avg. Body Weight Reduction
94%
Patient Satisfaction Rate
Latest Discoveries

GLP-1 Research Highlights

Semaglutide Reduces Cardiovascular Risk by 20% in Landmark SELECT Trial
Featured

April 10, 2026 · Clinical Research

Semaglutide Reduces Cardiovascular Risk by 20% in Landmark SELECT Trial

The SELECT trial involving 17,604 overweight adults demonstrated that weekly semaglutide injections significantly reduced major adverse cardiovascular events, establishing GLP-1 receptor agonists as a cornerstone of cardiometabolic therapy.

Read full study
Tirzepatide Achieves 22.5% Weight Loss in SURMOUNT-1 Phase 3 Trial

March 28, 2026 · Weight Loss

Tirzepatide Achieves 22.5% Weight Loss in SURMOUNT-1 Phase 3 Trial

Read
GLP-1 Agonists Now Recommended as First-Line Therapy for Type 2 Diabetes

March 14, 2026 · Diabetes

GLP-1 Agonists Now Recommended as First-Line Therapy for Type 2 Diabetes

Read
All Research Highlights →
What's New

GLP-1 News & Updates

FDA UpdateApril 18, 2026

FDA Approves First Oral GLP-1 Medication for Chronic Weight Management

The FDA has approved the first oral GLP-1 receptor agonist for chronic weight management, expanding access for patients who prefer pills over injections.

Read full story
ResearchApril 15, 2026

GLP-1 Use Associated with 40% Lower Risk of Alzheimer's Disease in Large Study

A large observational study of 1.2 million patients found that GLP-1 receptor agonist users had significantly lower rates of Alzheimer's disease diagnosis over a 10-year follow-up period.

Read full story
PolicyApril 11, 2026

Medicare Expands GLP-1 Coverage to Include Obesity Without Diabetes

CMS announced expanded Medicare Part D coverage for GLP-1 medications prescribed for obesity, potentially benefiting over 3.4 million beneficiaries.

Read full story
TelehealthApril 8, 2026

Telehealth GLP-1 Prescriptions Surge 340% as Regulatory Barriers Ease

Online prescribing platforms report record demand for GLP-1 consultations as regulatory changes make it easier for patients to access these medications remotely.

Read full story

How to Buy GLP-1

Step-by-step guide to getting a prescription, choosing a pharmacy, and saving money on GLP-1 medications.

Buying Guide

Telehealth Options

Get a GLP-1 prescription online from licensed providers. Compare top telehealth platforms by cost, speed, and drug availability.

Compare Platforms

Cost & Insurance

GLP-1 medications can cost $900+/month. Learn about manufacturer coupons, insurance coverage, and compounding options.

Save on GLP-1
Peer-Reviewed Sources Only
Medically Reviewed Content
FDA-Compliant Information
Updated Monthly
No Sponsored Content